Ketamine Completed Phase 4 Trials for Pain, Acute / Sickle Cell Crisis Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02817477Intranasal Ketamine for Acute Traumatic Pain
NCT02434939Low-dose Ketamine vs Morphine for Vaso-occlusive Crisis in Sicklers